Xtant Medical Holdings, Inc.
XTNT
$0.612
-$0.008-1.29%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.62% | 4.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.62% | 4.41% | |||
| Cost of Revenue | -12.12% | -18.26% | |||
| Gross Profit | 19.96% | 26.33% | |||
| SG&A Expenses | 1.91% | 7.78% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.31% | -4.65% | |||
| Operating Income | 335.00% | 156.48% | |||
| Income Before Tax | 11,430.30% | 101.05% | |||
| Income Tax Expenses | 1,120.00% | -219.05% | |||
| Earnings from Continuing Operations | 6,020.69% | 101.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6,020.69% | 101.83% | |||
| EBIT | 335.00% | 156.48% | |||
| EBITDA | 171.08% | 391.14% | |||
| EPS Basic | 6,275.00% | 102.00% | |||
| Normalized Basic EPS | 17,000.00% | 100.81% | |||
| EPS Diluted | 4,900.00% | 102.00% | |||
| Normalized Diluted EPS | 15,900.00% | 100.81% | |||
| Average Basic Shares Outstanding | 0.17% | -12.12% | |||
| Average Diluted Shares Outstanding | 3.66% | -9.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||